Announcements
- Eurobio Scientific : bilan semestriel du contrat de liquidité
- EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®
- EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST D'EXPRESSION GÉNIQUE POUR LE CANCER DU SEIN ENDOPREDICT®
- Eurobio Scientific : mise à disposition du rapport financier annuel 2023
- Eurobio Scientific : Rapport Financier Annuel 2023
- EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
- EUROBIO SCIENTIFIC: RESULTAT ANNUEL 2023
- Eurobio Scientific : EXERCICE 2023, CONFIRMATION DE LA TRANSFORMATION STRATEGIQUE
- Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP
- EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
More ▼
Key statistics
On Friday, Eurobio Scientific SA (E8TN:DUS) closed at 13.72, 0.88% above its 52-week low of 13.60, set on Jul 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.72 |
---|---|
High | 13.72 |
Low | 13.72 |
Bid | 13.74 |
Offer | 14.06 |
Previous close | 13.78 |
Average volume | 0.00 |
---|---|
Shares outstanding | 10.25m |
Free float | 5.01m |
P/E (TTM) | 31.98 |
Market cap | 141.43m EUR |
EPS (TTM) | 0.4315 EUR |
Data delayed at least 15 minutes, as of Jul 05 2024 07:12 BST.
More ▼